Cargando…

Dietary Antioxidants, Macular Pigment, and Glaucomatous Neurodegeneration: A Review of the Evidence

Primary open-angle glaucoma (POAG) is a leading cause of irreversible blindness worldwide, and the prevalence is projected to increase to 112 million worldwide by 2040. Intraocular pressure is currently the only proven modifiable risk factor to treat POAG, but recent evidence suggests a link between...

Descripción completa

Detalles Bibliográficos
Autores principales: Lawler, Thomas, Liu, Yao, Christensen, Krista, Vajaranant, Thasarat S., Mares, Julie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6567242/
https://www.ncbi.nlm.nih.gov/pubmed/31052471
http://dx.doi.org/10.3390/nu11051002
_version_ 1783427031696932864
author Lawler, Thomas
Liu, Yao
Christensen, Krista
Vajaranant, Thasarat S.
Mares, Julie
author_facet Lawler, Thomas
Liu, Yao
Christensen, Krista
Vajaranant, Thasarat S.
Mares, Julie
author_sort Lawler, Thomas
collection PubMed
description Primary open-angle glaucoma (POAG) is a leading cause of irreversible blindness worldwide, and the prevalence is projected to increase to 112 million worldwide by 2040. Intraocular pressure is currently the only proven modifiable risk factor to treat POAG, but recent evidence suggests a link between antioxidant levels and risk for prevalent glaucoma. Studies have found that antioxidant levels are lower in the serum and aqueous humor of glaucoma patients. In this review, we provide a brief overview of the evidence linking oxidative stress to glaucomatous pathology, followed by an in-depth discussion of epidemiological studies and clinical trials of antioxidant consumption and glaucomatous visual field loss. Lastly, we highlight a possible role for antioxidant carotenoids lutein and zeaxanthin, which accumulate in the retina to form macular pigment, as evidence has emerged supporting an association between macular pigment levels and age-related eye disease, including glaucoma. We conclude that the evidence base is inconsistent in showing causal links between dietary antioxidants and glaucoma risk, and that prospective studies are needed to further investigate the possible relationship between macular pigment levels and glaucoma risk specifically.
format Online
Article
Text
id pubmed-6567242
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-65672422019-06-17 Dietary Antioxidants, Macular Pigment, and Glaucomatous Neurodegeneration: A Review of the Evidence Lawler, Thomas Liu, Yao Christensen, Krista Vajaranant, Thasarat S. Mares, Julie Nutrients Review Primary open-angle glaucoma (POAG) is a leading cause of irreversible blindness worldwide, and the prevalence is projected to increase to 112 million worldwide by 2040. Intraocular pressure is currently the only proven modifiable risk factor to treat POAG, but recent evidence suggests a link between antioxidant levels and risk for prevalent glaucoma. Studies have found that antioxidant levels are lower in the serum and aqueous humor of glaucoma patients. In this review, we provide a brief overview of the evidence linking oxidative stress to glaucomatous pathology, followed by an in-depth discussion of epidemiological studies and clinical trials of antioxidant consumption and glaucomatous visual field loss. Lastly, we highlight a possible role for antioxidant carotenoids lutein and zeaxanthin, which accumulate in the retina to form macular pigment, as evidence has emerged supporting an association between macular pigment levels and age-related eye disease, including glaucoma. We conclude that the evidence base is inconsistent in showing causal links between dietary antioxidants and glaucoma risk, and that prospective studies are needed to further investigate the possible relationship between macular pigment levels and glaucoma risk specifically. MDPI 2019-05-01 /pmc/articles/PMC6567242/ /pubmed/31052471 http://dx.doi.org/10.3390/nu11051002 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Lawler, Thomas
Liu, Yao
Christensen, Krista
Vajaranant, Thasarat S.
Mares, Julie
Dietary Antioxidants, Macular Pigment, and Glaucomatous Neurodegeneration: A Review of the Evidence
title Dietary Antioxidants, Macular Pigment, and Glaucomatous Neurodegeneration: A Review of the Evidence
title_full Dietary Antioxidants, Macular Pigment, and Glaucomatous Neurodegeneration: A Review of the Evidence
title_fullStr Dietary Antioxidants, Macular Pigment, and Glaucomatous Neurodegeneration: A Review of the Evidence
title_full_unstemmed Dietary Antioxidants, Macular Pigment, and Glaucomatous Neurodegeneration: A Review of the Evidence
title_short Dietary Antioxidants, Macular Pigment, and Glaucomatous Neurodegeneration: A Review of the Evidence
title_sort dietary antioxidants, macular pigment, and glaucomatous neurodegeneration: a review of the evidence
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6567242/
https://www.ncbi.nlm.nih.gov/pubmed/31052471
http://dx.doi.org/10.3390/nu11051002
work_keys_str_mv AT lawlerthomas dietaryantioxidantsmacularpigmentandglaucomatousneurodegenerationareviewoftheevidence
AT liuyao dietaryantioxidantsmacularpigmentandglaucomatousneurodegenerationareviewoftheevidence
AT christensenkrista dietaryantioxidantsmacularpigmentandglaucomatousneurodegenerationareviewoftheevidence
AT vajaranantthasarats dietaryantioxidantsmacularpigmentandglaucomatousneurodegenerationareviewoftheevidence
AT maresjulie dietaryantioxidantsmacularpigmentandglaucomatousneurodegenerationareviewoftheevidence